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Background: Multiple chronic conditions and low skeletal muscle mass are common features of aging that are
detrimental to physical performance. This study evaluates the simultaneous impact of these conditions on physical
performance in older adults.
Methods: Five studies from 2003 to 2012 were pooled to include 2,398 adults aged ≥65 years with diagnosed
chronic diseases measured by self-administered questionnaire. Low muscle mass was defined as an appendicular
skeletal muscle mass index less than that of the sex-specific lowest quintile in the population of older adults. Poor
physical performances were defined as the lowest quintile of grip strength and gait speed in the population of
older adults and the slowest sex-specific 20% of Timed Up and Go (TUG) test at each study site. Chi-squared and
logistic regression tests were applied for data analysis.
Results: Mean age of the study participants, of whom approximately 50% were men, was 74.3 years. Slow gait
speed was nearly three times more likely to occur in the presence of low muscle mass coupled with chronic
disease than in the absence of both factors after adjustment for study site, age, sex, education, marital status,
body mass index, tobacco and alcohol use, and comorbidities. The independent effect of low muscle mass was
generally stronger than that of each disease. Participants with more than two chronic diseases and low muscle
mass were significantly more likely to perform poorly than those with no risk factors (odds ratio [OR] = 2.51 in
patients with low grip strength, OR = 3.89 in patients with low gait speed, and OR = 3.67 in patients with poor
TUG test scores, all P < 0 .05) after adjustment.
Conclusions: The combined association of chronic disease and low skeletal mass with physical performance
was stronger than the effect of either factor alone.
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The proportion of older adults (>65 y) in the overall
population is growing in numerous countries [1]. With
aging comes impaired physical performance, which is
correlated with incident functional limitation in daily ac-
tivities [2,3] and is a predictor of adverse health effects
such as hospitalization, severe limitation of mobility, and
death [4]. To prevent such impairment, individuals at
high risk can be identified by determining the factors
contributing to physical performance. Studies have indi-
cated that low muscle mass and chronic disease are linked
to poor physical performance [5-12] and that age-related
loss of skeletal muscle mass is a common phenomenon
among older adults [12]. One study reported the preva-
lence of low muscle mass to increase from 8.9% in women
aged 76–80 years to 10.9% at 86–95 years of age [13].
Muscle mass has been reported to decline 1–2% annually
after age 50 years [14], which contributes to a decline in
muscle strength [5,15]. The link between muscle mass and
physical performance remains controversial. Some studies
have indicated that low muscle mass is associated with
low grip strength and poor mobility in older men and
women [5,6,16], whereas others have observed no such
association [15,17,18].
Previous studies have reported that low muscle strength
and impaired physical performance have been linked to
chronic diseases, including diabetes [9,10,19], hyperten-
sion [8], arthritis [12], and osteoporosis [11]. Older people
with diabetes have less muscle strength and a slower gait
than those without diabetes [9,10,19], and those with arth-
ritis have less muscle strength than the general population
at a similar age [12]. One prospective study revealed that
having two or more chronic diseases is associated with a
greater decline in grip strength than having no chronic
disease [8]. The co-occurrence of low muscle mass and
chronic disease is common as people age, and both factors
are associated with poor physical function. However, the
combined association of chronic disease and low muscle
mass with physical function has not yet been examined.
Therefore, in this study we explored the combined associ-




Our pooled dataset was derived from 5 cohort studies of
community-dwelling older adults from 2003 to 2012 that
constitute the study entitled Sarcopenia and Translational
Aging Research in Taiwan (START) [20]. We used 4 studies,
excluding one study in which body composition was not
measured. The four individual cohort studies comprising
the present study were Healthy Aging Longitudinal Study in
Taiwan (HALST) (n = 990), Taichung Community Health
Study for the Elderly (TCHS-E) (n = 1042), Tianliao OldPeople (TOP) study (n = 549), and Comprehensive Geriatric
Assessment and Frailty Study of Elderly Outpatients
(CGAFSEO) (n = 431) [21-23]. These studies recruited
subjects representative of older residents living in the
northern (HALST, CGAFSEO), central (TCHS-E), and
southern (HALST, TOP) regions of Taiwan. For the
studies that are still ongoing (follow-up phase), only
baseline data are reported here. All of the cohort stud-
ies had written informed consent, and were approved
by the respective institutional review boards (HALST
and CGAFSEO by Medical Research Ethics Committee
of National Health Research Institutes and Research
Ethics Committee of the National Taiwan University
Hospital, TCHS-E by Institutional Review Board of
China Medical University, TOP by Research Ethics
Committee of National Cheng Kung University, and
IPFCEH by Research Ethics Committee of Hualien Tzu
Chi Hospital).
Our pooled data were therefore for 3,012 subjects ran-
ging in age from 55 to 102 years (Figure 1). We excluded
subjects aged younger than 65 years; those with cancer,
stroke, and low cognitive function; and those with in-
complete information on muscle mass and chronic dis-
ease. The exclusion criteria for stroke and cancer were
applied on the basis of patients’ self-reported illness di-
agnosed by physicians. Subjects’ cognitive status was mea-
sured with the Mini-Mental State Examination (MMSE)
at three study sites and the Short Portable Mental Status
Questionnaire (SPMSQ) at one study site. For studies
using the MMSE, low cognition was defined as a score
of <18 in subjects with ≤9 years of education or a score
of <25 in subjects with >9 years of education. For the
study using the SPMSQ, low cognition was defined as four
or more incorrect answers in subjects with ≤9 years of
education, three or more incorrect answers in subjects
with high school education, and two or more incorrect an-
swers in subjects with senior high school education or
higher. Ultimately, 2,398 community-dwelling older adults
with a mean age of 74.3 ± 6.1 years were analyzed in this
study. The study was approved by the institutional review
boards at each site, and written informed consent was
provided by each participant.
Measurements
Low muscle mass
All participants underwent a standardized procedure for
measuring body composition with an eight-contact-electrode
bioelectrical impedance analysis device (Tanita BC-418;
Tanita Corp., Tokyo, Japan) [24]. The device measures
whole-body and segmental impedance (±1Ω) at a frequency
of 50 kHz and provides valid estimates of muscle mass (kg)
in all four extremities [25]. Appendicular muscle mass was
calculated as the sum of the estimated muscle mass of the
arms and legs. Appendicular muscle mass index (ASMI)
Pooled database from 4 study sites
3012 study subjects (age range 55~102)
2398 elders aged 65~99 years were analyzed
614 subjects excluded
277 were aged less than 65 years
21 had disease history of cancer and stroke
155 were low cognition function
177 had incomplete information of muscle mass and chronic diseases
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Figure 1 Flowchart of study subjects.
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lar muscle mass (kg) to height squared (m2) [18,25]. Muscle
mass was considered low if ASMI was in the lowest
20% of the sex-specific distribution in the study popula-
tion (7.11 kg/m2 for men and 5.63 kg/m2 for women).
Physical performance
Functional performance was assessed using the hand
grip strength test, gait speed, and Timed Up and Go
(TUG) test. Hand grip strength (kg) was measured using
a standard calibrated hand dynamometer. The average
grip strength of dominant hand was used in analysis.
Participants who ranked in the lowest 20% for sex and
body mass index (BMI)-specific distribution were con-
sidered to have low grip strength [26]. To measure gait
speed, the participants walked at their typical pace over
a fixed distance ranging from 3 to 5 m at different study
sites [27]. Gait speed was determined by dividing the
walking distance by total walking time, and participants
ranking in the lowest 20% for sex- and height-specific
distributions were considered to have a slow gait [26].
The cutoff points of gait speed and hand grip strength
were published in our previous study [20]. Three study
sites performed the TUG test, in which each participant
stood in front of a chair of standard height, walked 3 m,
turned, and returned to a sitting position in the chair
[28]. At two of the three sites, subjects were asked to
complete the TUG test at their usual pace, and at the
third, subjects were asked to perform the test as quickly
as possible [29]. Because the distributions of time requiredto complete the TUG test differed at different sites, site-
specific distributions for TUG test results were used. Par-
ticipants for whom the time required to complete the
TUG test ranked in the highest 20% for sex by site were
considered to have poor functional mobility.
Chronic disease
Data on chronic disease were collected using a self-
report questionnaire. Patients were asked whether they
had diabetes, hypertension, heart disease, chronic ob-
structive pulmonary disease (COPD), chronic kidney dis-
ease (CKD), arthritis, or osteoporosis. Comorbidity was
measured as the total number of 7 chronic diseases and
categorized as 0, 1, and 2 or more.
Covariates
Data on the sociodemographic characteristics and health-
related behaviors of the participants, including age, sex,
education, marital status, obesity status, smoking status,
alcohol use, and physical activity level, were collected
using a questionnaire. BMI, calculated as body weight (kg)
divided by the square of height (m), was used to classify
obesity status as underweight (<18.5 kg/m2), normal
(18.5–24 kg/m2), overweight (24–26.9 kg/m2), or obese
(≥27 kg/m2), as defined by the Taiwan Department of
Health [30]. Energy expenditure through physical ac-
tivity was derived from a standardized questionnaire.
Information on various leisure activities and time spent
per week performing each activity were obtained. Physical-
activity energy expenditure per person was calculated as
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plied by typical energy expenditure and expressed in
kilocalories expended per kilogram of body weight per
week (kcal/kg/week) [31]. Participants were divided into
site- and sex-specific tertiles of total energy expenditure
from physical activity.
Statistical analysis
To examine the correlations between physical perform-
ance and covariates (sociodemographic characteristics,
obesity status, and health behaviors) and chronic disease,
we compared the proportion in each covariate and
chronic disease between participants with and without
poor physical performance using the chi-square test.
To test the combined association of chronic disease
and muscle mass on physical performance, five com-
mon chronic diseases, each with a prevalence of >10%
in older adults, were analyzed: diabetes, hypertension,
heart disease, arthritis, and osteoporosis (COPD and
CKD were excluded). Unadjusted odds ratio (OR) and
95% confidence interval (CI) were used to assess the
combined association of chronic disease and muscle
mass with physical performance, and multiple logistic
regression was used to adjust for covariates. Two-sided
P values were calculated and statistical significance set
at P < 0.05. Analyses were performed using SAS® software
version 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
Table 1 presents sociodemographic factors, health be-
haviors, chronic diseases, and low muscle mass catego-
rized by low grip strength, gait speed, and TUG test
performance. The combined association of chronic dis-
ease and low muscle mass with physical performance is
presented in Table 1. The independent effect of low muscle
mass significantly increased the odds of low grip strength
among participants without hypertension (OR = 1.93), arth-
ritis (OR = 1.72), or osteoporosis (OR = 1.65). We did not
observe an independent effect of each disease on grip
strength. While diabetes and low muscle mass coexisted,
the increased odds of low grip strength (OR = 2.43) was
observed in participants.
The combined association of low muscle mass and
chronic disease with gait speed exceeded the association of
each factor alone. Independent associations of low muscle
mass and slow gait were observed when diabetes (OR =
2.03), heart disease (OR = 1.73), hypertension (OR = 2.20),
arthritis (OR = 1.88), or osteoporosis (OR = 1.90) was con-
sidered. An independent effect of chronic disease on gait
speed was observed, with higher odds of slow gait signifi-
cantly associated with diabetes, hypertension, and arthritis
(OR = 1.76, 1.39, and 1.47, respectively; P < 0.05 for all).
The likelihood of slow gait was far higher in the presence
of both low muscle mass and chronic disease (OR = 2.73for diabetes, OR = 2.97 for heart disease, OR = 2.38 for
hypertension, OR = 3.06 for arthritis, and OR = 2.78 for
osteoporosis, (P < 0.05) than in the absence of both factors
(Table 2).
The combined association of chronic disease and low
muscle mass with TUG score was stronger than the in-
dependent effect of either factor alone after adjustment
for confounding factors. The ORs of a low TUG test
score for low muscle mass alone were 1.65 when consid-
ering diabetes and 2.31 when considering hypertension
(P < 0.05 for both), and the relative odds for diabetes
and hypertension alone were 1.90 and 2.02, respect-
ively (P < 0.05). The ORs of a low TUG score were sig-
nificant in the presence of low muscle mass and heart
disease (OR = 2.48), hypertension (OR = 2.26), arthritis
(OR = 2.93), or osteoporosis (OR = 2.25) (P < 0.05 for
all), but not in the presence of low muscle mass with
diabetes (Table 2).
Finally, we explored the combined association of mul-
tiple chronic diseases and low muscle mass. Participants
with more than two chronic diseases and low muscle mass
were more likely to perform poorly than those with no
risk factors (OR = 2.51 for low grip strength, OR = 3.89 for
slow gait, and OR = 3.67 for low TUG score, P < 0.05) after
adjustment for confounding factors. Compared with par-
ticipants with no risk factors, the odds of poor physical
performance among those having one chronic disease and
low muscle mass were higher than among participants
with two or more chronic diseases and normal muscle
mass (OR = 2.42 vs. 1.90 for low grip strength, OR = 3.17
vs. 2.22 for slow gait, and OR = 3.08 vs. 2.80 for a low
TUG score; P < 0.05) (Figure 2).
Discussion
In the present study, we examined the combined associ-
ation of low muscle mass and chronic disease with phys-
ical performance in older adults. Participants with low
muscle mass and chronic comorbidities had lower grip
strength, slower gait, and lower TUG score than those
with low muscle mass alone or chronic disease alone,
even after we controlled for potential confounding fac-
tors. Furthermore, low muscle mass alone is more
strongly associated with greater impairment in physical
performance than is chronic disease alone.
Low muscle mass has been reported to be significantly
associated with impaired physical performance in older
adults [5,6,11,19,32-34]. A community-based study of
4,000 older adults linked low muscle mass to weaker
grip strength in both sexes after adjusting for age [34].
Some studies have reported that older women with
lower muscle mass exhibit slower gait [5,6,34]. In the
United States, the third National Health and Nutrition
Examination Survey reported that even after adjustment
for confounding variables, low muscle mass hindered
Table 1 Effects of socio-demographic factors, health behavior, chronic disease, and muscle mass on physical
performance
Grip strength Gait speed TUG test performance
Normal Low Normal Low Normal Low
Variables n (%) n (%) p-value n (%) n (%) p-value n (%) n (%) p-value
Socio-demographic variables
Age (years) <0.001 <0.001 <0.001
65-69 602 (30.54) 61 (14.91) 611 (31.58) 51 (11.78) 553 (35.96) 34 (8.92)
70-74 609 (30.90) 80 (19.56) 599 (30.96) 89 (20.55) 467 (30.36) 81 (21.26)
75-79 435 (22.07) 100 (24.45) 427 (22.07) 106 (24.48) 301 (19.57) 100 (26.25)
≥80 325 (16.49) 168 (41.08) 298 (15.40) 187 (43.19) 217 (14.11) 166 (43.57)
Gender <0.001 0.579 0.959
Woman 964 (48.91) 236 (57.70) 968 (50.03) 223 (51.50) 793 (51.56) 197 (51.71)
Man 1007 (51.09) 173 (42.30) 967 (49.97) 210 (48.50) 745 (48.44) 184 (48.29)
Education years 0.003 <0.001 <0.001
≤6 998 (51.23) 241 (59.21) 969 (50.55) 263 (61.74) 619 (40.62) 213 (57.10)
>6 950 (48.77) 166 (40.79) 948 (49.45) 163 (38.26) 905 (59.38) 160 (42.90)
Marital status 0.927 0.002 0.7480
Married 1718 (96.35) 282 (96.25) 1634 (96.97) 359 (93.73) 1250 (95.64) 299 (95.22)
Unmarried 65 (3.65) 11 (3.75) 51 (3.03) 24 (6.27) 57 (4.36) 15 (4.78)
BMI (kg/m2) 0.737 <0.001 <0.001
<18.5 66 (3.35) 15 (3.67) 57 (2.95) 24 (5.54) 42 (2.73) 17 (4.46)
18.5-24 828 (42.01) 162 (39.61) 832 (43.00) 155 (35.80) 665 (43.24) 141 (37.01)
24-27 633 (32.12) 131 (32.03) 630 (32.56) 126 (29.10) 506 (32.90) 105 (27.56)
≥27 444 (22.53) 101 (24.69) 416 (21.50) 128 (29.56) 325 (21.13) 118 (30.97)
Health behavior
Smoking 0.150 0.641 0.723
No 1820 (92.34) 386 (94.38) 1793 (92.66) 404 (93.30) 1429 (92.91) 352 (92.39)
Yes 151 (7.66) 23 (5.62) 142 (7.34) 29 (6.70) 109 (7.09) 29 (7.61)
Alcohol drink 0.001 0.010 0.016
No 1610 (81.68) 361 (88.26) 1583 (81.81) 377 (87.07) 1224 (79.58) 324 (85.04)
Yes 361 (18.32) 48 (11.74) 352 (18.19) 56 (12.93) 314 (20.42) 57 (14.96)
Physical activity a <0.001 <0.001 <0.001
Low 560 (29.61) 190 (48.10) 541 (29.01) 195 (47.68) 404 (27.54) 186 (51.24)
Normal 627 (33.16) 127 (32.15) 621 (33.30) 135 (33.01) 504 (34.36) 106 (29.20)
High 704 (37.23) 78 (19.75) 703 (37.69) 79 (19.32) 559 (38.10) 71 (19.56)
Chronic disease
Diabetes <0.001 <0.001 <0.001
No 1590 (80.67) 287 (70.17) 1563 (80.78) 310 (71.59) 1232 (80.10) 266 (69.82)
Yes 381 (19.33) 122 (29.83) 372 (19.22) 123 (28.41) 306 (19.90) 115 (30.18)
Hypertension <0.001 <0.001 <0.001
No 910 (46.17) 125 (30.56) 886 (45.79) 147 (33.95) 693 (45.06) 110 (28.87)
Yes 1061 (53.83) 284 (69.44) 1049 (54.21) 286 (66.05) 845 (54.94) 271 (71.13)
Heart disease 0.260 <0.001 <0.001
No 1604 (81.38) 323 (78.97) 1599 (82.64) 318 (73.44) 1246 (81.01) 275 (72.18)
Yes 367 (18.62) 86 (21.03) 336 (17.36) 115 (26.56) 292 (18.99) 106 (27.82)
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performance (Continued)
COPD 0.225 0.706 0.294
No 1916 (97.21) 393 (96.09) 1879 (97.11) 419 (96.77) 1490 (96.88) 365 (95.80)
Yes 55 (2.79) 16 (3.91) 56 (2.89) 14 (3.23) 48 (3.12) 16 (4.20)
CKD 0.010 0.519 0.729
No 1836 (93.15) 366 (89.49) 1788 (92.40) 404 (93.30) 1421 (92.39) 350 (91.86)
Yes 135 (6.85) 43 (10.51) 147 (7.60) 29 (6.70) 117 (7.61) 31 (8.14)
Arthritis <0.001 <0.001 <0.001
No 1528 (77.52) 259 (63.33) 1484 (76.69) 295 (68.13) 1166 (75.81) 251 (65.88)
Yes 443 (22.48) 150 (36.67) 451 (23.31) 138 (31.87) 372 (24.19) 130 (34.12)
Osteoporosis 0.212 <0.001 0.001
No 1618 (82.09) 325 (79.46) 1611 (83.26) 321 (74.13) 1264 (82.18) 283 (74.28)
Yes 353 (17.91) 84 (20.54) 324 (16.74) 112 (25.87) 274 (17.82) 98 (25.72)
Muscle mass
Low ASMI 0.009 <0.001 0.005
No 1601 (81.23) 309 (75.55) 1588 (82.07) 311 (71.82) 1207 (78.48) 273 (71.65)
Yes 370 (18.77) 100 (24.45) 347 (17.93) 122 (28.18) 331 (21.52) 108 (28.35)
Abbreviations: TUG, Timed Up and Go; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CKD: chronic kidney disease; ASMI: Appendicular
Skeletal Muscle Mass Index.
aPhysical activity categorized according to sex-specific tertiles of physical activity.
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sectional study analyzing 183 community-dwelling older
adults using baseline data from a randomized control
trial [11] and a community-based study of 409 older
women [35] indicated that higher muscle mass is associ-
ated with a better TUG test score. These results pro-
vided evidence that muscle mass is highly correlated
with physical performance in older adults.
Unlike the aforementioned studies, which reported the
contribution of low muscle mass to physical performance,
our study also assessed the effect of chronic disease while
considering the combined contribution of muscle mass and
chronic disease to the risk of poor physical performance in
older adults. After we considered these diseases, our results
were consistent with those of previous studies of the effect of
muscle mass on gait speed [5,6,34]. Our data regarding the
effect of muscle mass on grip strength were consistent with
those of a previous study [34] when only hypertension, arth-
ritis, and osteoporosis were considered, but were not signifi-
cant for diabetes and heart disease. The effect on TUG score
was similar when we considered heart disease, hypertension,
arthritis, and osteoporosis, and was nonsignificant when we
considered diabetes. The effects might not have been ob-
served when chronic conditions were considered because of
the presence of comorbidities in older adults.
We observed that older adults with diabetes or hyper-
tension exhibited poor lower-extremity physical per-
formance. This is consistent with the findings of two
studies reporting that older diabetic adults had a slower
gait and less muscle strength than older adults withoutdiabetes [9,19], and with the results of a study that
followed older adults for 18 years and found that higher
systolic blood pressure was associated with a higher rate
of decline in gait speed [36]. Poor muscle function in
diabetic patients could be the result of neuropathic pro-
cesses due to diabetic polyneuropathy, which involves
motor neurons [37], and the catabolic effect of inflam-
mation on muscles [38]. Our study further explored the
combined association of low muscle mass and diabetes
and our results showed that elders with low muscle
mass and muscle dysfunction due to diabetic polyneur-
opathy and muscle inflammation may further worsen
old adults’ physical activity performance including poor
hand grip strength and low gait speed. The magnitude
of strength of association for both low muscle mass and
diabetes was much greater than that either for low
muscle mass alone or diabetes alone. The hypertension
effect may be attributable to vascular-related damage
in the musculoskeletal and peripheral nervous systems
[39]. Our study finding demonstrated that an elder
with low muscle mass further suffering from vascular-
related damage to the musculoskeletal and peripheral
nervous system by hypertension may impede elders’
function performance including low gait speed and
poor TUG test performance. Again, the strength of as-
sociation for both low muscle mass and hypertension
was stronger than that either for low muscle mass
alone or hypertension alone. Our study was the first
one to estimate the strength of joint association be-
tween low lean muscle mass and chronic diseases.







Low grip strength Low gait speed Low TUG test performance
n (%) ORcrud (95%CI) ORadj (95%CI) n (%) ORcrud (95%CI) ORadj (95%CI) n (%) ORcrud (95%CI) ORadj (95%CI)
Diabetes
No No 1497 211 (14.09) 1.00 1.00 212 (14.16) 1.00 1.00 179 (11.96) 1.00 1.00
No Yes 396 76 (19.19) 1.46 (1.09, 1.95) 1.52 (0.93, 2.48) 98 (24.75) 1.99 (1.52, 2.61) 2.03 (1.31, 3.12) 87 (21.97) 1.63 (1.22, 2.18) 1.65 (1.02, 2.68)
Yes No 426 98 (23) 1.82 (1.39, 2.38) 1.36 (0.95, 1.96) 99 (23.24) 1.85 (1.42, 2.42) 1.76 (1.25, 2.47) 94 (22.07) 1.93 (1.45, 2.57) 1.90 (1.29, 2.79)
Yes Yes 79 24 (30.38) 2.64 (1.60, 4.35) 2.43 (1.14, 5.17) 24 (30.38) 2.76 (1.67, 4.57) 2.73 (1.33, 5.59) 21 (26.58) 2.32 (1.36,3.97) 1.95 (0.87, 4.37)
Heart disease
No No 1581 246 (15.56) 1.00 1.00 237 (14.99) 1.00 1.00 202 (12.78) 1.00 1.00
No Yes 362 77 (21.27) 1.47 (1.11, 1.96) 1.56 (0.95, 2.56) 81 (22.38) 1.65 (1.24, 2.19) 1.73 (1.09, 2.73) 73 (20.17) 1.38 (1.03, 1.87) 1.38 (0.82, 2.35)
Yes No 342 63 (18.42) 1.22 (0.90, 1.65) 1.19 (0.78, 1.83) 74 (21.64) 1.57 (1.17, 2.10) 1.23 (0.83, 1.80) 71 (20.76) 1.59 (1.17, 2.16) 1.43 (0.93, 2.21)
Yes Yes 113 23 (20.35) 1.39 (0.86, 2.24) 1.94 (0.94, 3.99) 41 (36.28) 3.18 (2.12, 4.78) 2.97 (1.65, 5.34) 35 (30.97) 2.35 (1.53, 3.61) 2.48 (1.32, 4.65)
Hypertension
No No 797 83 (10.41) 1.00 1.00 92 (11.54) 1.00 1.00 62 (7.78) 1.00 1.00
No Yes 248 42 (16.94) 1.77 (1.19, 2.65) 1.93 (1.06, 3.52) 55 (22.18) 2.19 (1.51, 3.17) 2.20 (1.30, 3.72) 48 (19.35) 2.24 (1.48, 3.39) 2.31 (1.25, 4.25)
Yes No 1126 226 (20.07) 2.16 (1.65, 2.83) 1.27 (0.90, 1.79) 219 (19.45) 1.86 (1.43, 2.42) 1.39 (1.00, 1.91) 211 (18.74) 2.53 (1.87, 3.44) 2.02 (1.37, 2.98)
Yes Yes 227 58 (25.55) 2.95 (2.02, 4.29) 1.72 (0.97, 3.05) 67 (29.52) 3.23 (2.25, 4.62) 2.38 (1.43, 3.99) 60 (26.43) 3.26 (2.19, 4.85) 2.26 (1.27, 4.03)
Arthritis
No No 1426 189 (13.25) 1.00 1.00 205 (14.38) 1.00 1.00 177 (12.41) 1.00 1.00
No Yes 373 70 (18.77) 1.52 (1.12, 2.05) 1.72 (1.05, 2.81) 90 (24.13) 1.89 (1.43, 2.50) 1.88 (1.22, 2.90) 74 (19.84) 1.38 (1.02, 1.87) 1.28 (0.78, 2.10)
Yes No 497 120 (24.14) 2.09 (1.62, 2.70) 1.30 (0.91, 1.86) 106 (21.33) 1.62 (1.25, 2.11) 1.47 (1.05, 2.06) 96 (19.32) 1.56 (1.18, 2.06) 1.18 (0.80, 1.75)
Yes Yes 102 30 (29.41) 2.79 (1.77, 4.39) 1.60 (0.75, 3.40) 32 (31.37) 2.81 (1.80, 4.38) 3.06 (1.52, 6.15) 34 (33.33) 2.87 (1.83, 4.50) 2.93 (1.41, 6.10)
Osteoporosis
No No 1574 245 (15.57) 1.00 1.00 227 (14.42) 1.00 1.00 203 (12.9) 1.00 1.00
No Yes 382 80 (20.94) 1.44 (1.09, 1.91) 1.65 (1.02, 2.68) 94 (24.61) 1.94 (1.48, 2.55) 1.90 (1.23, 2.93) 80 (20.94) 1.44 (1.07, 1.92) 1.44 (0.88, 2.35)
Yes No 349 64 (18.34) 1.22 (0.90, 1.66) 1.03 (0.70, 1.51) 84 (24.07) 1.89 (1.42, 2.51) 1.39 (0.97, 1.99) 70 (20.06) 1.59 (1.17, 2.17) 1.31 (0.86, 1.98)
Yes Yes 93 20 (21.51) 1.52 (0.91, 2.54) 1.35 (0.62, 2.98) 28 (30.11) 2.56 (1.61, 4.08) 2.78 (1.41, 5.48) 28 (30.11) 2.32 (1.44, 3.73) 2.25 (1.07, 4.71)
ASMI = Appendicular Skeletal Muscle Mass Index; BMI = body mass index; CI = confidence interval; OR = odds ratio; ORadj = OR adjusted for age, sex, education, BMI, site, tobacco, alcohol, marital status, physical











Figure 2 Risk of poor physical performance according to combined association of number of chronic diseases and low muscle mass,
adjusted for age, sex, education, BMI, study site, tobacco, alcohol, marital status, and physical activity. BMI = body mass index.
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of chronic diseases in elders.
We also observed that older adults with arthritis exhib-
ited slower gait and required a longer time to complete
the TUG test. A meta-analysis of 185 studies with 101,049
participants reported that individuals with rheumatoid
arthritis exhibited substantially less grip strength than
similar-aged individuals in the general population [12]. A
possible reason for the discrepancy between these results
and those of the present study is that we considered arth-
ritis to affect mainly the hips and knees, rather than the
hands, because of the low the prevalence of symptomatic
hand osteoarthritis in older Chinese adults (3.0% in men,
5.8% in women) [40]. The meta-analysis addressed grip
strength but did not focus on the lower extremities.
Our study examined the independent as well as the
combined associations of low muscle mass and various
chronic diseases with physical performance. The inde-
pendent association of low muscle mass was stronger
than that of each disease with grip strength and gait
speed, indicating that maintenance of muscle mass is
crucial to improving physical performance. Participants
with two or more chronic diseases and low muscle mass
performed more poorly than those with no risk factors
after we adjusted for confounding factors, which illustrates
the importance of physical training for older adults with
multiple chronic conditions. These findings suggest thatclinicians, public health workers, and investigators can
create strategies to prevent or slow the decline of physical
performance in these groups.
One limitation of this study was the differences in
measurement of physical performance at different study
sites. Inter-observer consistency of measurement could
not be verified. To control for the effect of this con-
founding factor, we used site-specific cutoff points to
define performance status as normal or abnormal. The
study site was added to multivariate models to control
for the effect of this confounder on the relationship
between muscle mass and comorbidities and physical
performance. Another limitation was assessment of chronic
disease by participant self-report without clinical confirm-
ation of a diagnosis. This may have led to underestimation
of disease prevalence; however, a previous study observed
that self-reported data on common chronic conditions ex-
hibit a moderate to strong agreement with medical records
[41]. We may have underestimated the independent effect
of chronic disease, or the combined association of chronic
disease and low muscle mass, with physical performance
through nondifferential misclassification.
Conclusion
In older adults, the co-occurrence of low muscle mass
and chronic disease contributed to a higher risk of im-
pairment of physical performance than did either factor
Li et al. BMC Geriatrics  (2015) 15:11 Page 9 of 10alone. The independent association between low muscle
mass and physical-performance impairment was much
stronger than that between each disease and physical-
performance impairment.
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